Karen Chagin

Company: Adaptimmune Therapeutics plc.

Job title: Senior Vice President Early Development

Seminars:

Roundtable: Endurance Unveiled: TCR Therapies Showcasing Durability in Solid Tumors 3:15 pm

• Discuss key clinical trials highlighting the enduring efficacy of TCR therapies in solid tumors, emphasizing long-term patient responses and sustained anti-tumor effects • Explore the underlying mechanisms contributing to the durability of TCR therapies in solid tumors, delving into factors influencing persistence and resistance patterns • Engage patients and experts to discuss lived experiences…Read more

day: Conference Day One